FemTech Products Built HIPAA-Compliant From Day One, Not Bolted On
Three women's health platforms shipped. Cycle-aware hormone intelligence, a holistic women's health app with a practitioner portal, and a doula workforce platform. Each launched in eight weeks, each built by the same team you'd work with.
Women's Health Products Fail in Places Generic HealthTech Doesn't
Most healthcare app studios have built a patient portal or a telehealth flow. Women's health has its own failure modes, and they show up late: at a security review, at a payer conversation, at the moment a clinician asks whether the data is safe to act on. Here is the problem set we see repeatedly, and how we build around each one.
A direct-to-consumer cycle tracker, fertility app, or menopause tool with no provider relationship often falls outside HIPAA entirely. Founders hear “we're not a covered entity” and relax. The FTC's Health Breach Notification Rule, FTC Section 5, and state consumer health data laws apply anyway, and they apply to exactly the data women's health products collect. Reproductive data is the most scrutinised privacy category in US consumer health right now. Teams architect for a regulation that doesn't govern them, miss the one that does, and discover the gap during a funding diligence or a partnership review, when retrofitting is most expensive.
We map your regulatory position in the requirement clarification calls in Week 1, before architecture is committed. We build to HIPAA standards regardless of covered-entity status, because it is the bar your future clinical partners, payers, and enterprise buyers will hold you to. HIPAA compliance is embedded from day one, not bolted on at the end, and automated audit documentation ships with every release.
Most apps treat consent as an onboarding screen. Women's health data needs consent that is granular per data type, revocable at any point, and auditable after the fact. A user who shares cycle data with a coach but not with a research partner needs that distinction enforced in the data layer, not in a settings page that the backend ignores. Consent bolted on later means either a rebuild of the permission model or a product that can't honour a deletion request cleanly. Both are visible to an enterprise buyer.
Consent architecture is scoped at the architecture stage, alongside PHI boundaries and access control. Granular, revocable, auditable, and enforced at the data layer rather than the interface.
Hormone health, fertility, and maternal care all generate data across wearables, symptom logs, lab panels, and medical records. None of it arrives structured, connected, or clinically actionable. A dashboard that shows four separate feeds is not a clinical product. Without unification, the clinician can't act, the AI has nothing coherent to model, and the product stalls as a tracker.
This is exactly the Khalisa™ build. We unified four data streams per patient and integrated three wearable platforms into a single layer, then modelled each woman's reproductive lifespan computationally on top of it, covering four life stages end to end.
Tracking is a wellness feature. Prediction starts to look like guidance. Guidance aimed at a clinical decision may be software as a medical device. Most FemTech roadmaps cross that line in year two without anyone naming the moment. An FDA question discovered after launch forces either a feature rollback or a regulatory programme nobody budgeted.
We flag where your roadmap crosses into regulated territory during scoping, and architect the clinical layer so a regulated feature can be added without rebuilding the product around it. In Khalisa™, clinical output is surfaced through a clinician portal with review and override at every step, which keeps the human in the loop by design rather than as a patch.
Many FemTech products launch on a no-code or low-code stack to reach users fast. It works until it doesn't: crashes, retention damage, and a compliance posture that can't be evidenced. By the time the platform is failing, there are real users on it and no obvious migration path that doesn't mean downtime.
We have done this migration in production. AuraFem's consumer app was built on FlutterFlow and crashing constantly, threatening both user retention and HIPAA compliance. We migrated it to a custom HIPAA-compliant Flutter build with zero downtime, and delivered a full practitioner portal inside the same eight-week engagement.
FemTech products are usually designed consumer-first. Then health coaches, doulas, midwives, or clinicians come aboard and have no tools: no client management, no scheduling, no messaging, no way to get paid. Revenue stalls because the supply side of the marketplace can't operate. A consumer app with no practitioner layer cannot support a B2B2C model, which is where most women's health revenue eventually lives.
We build both sides in the same engagement. AuraFem's practitioner portal, covering client management, scheduling, messaging, and billing, shipped alongside the consumer migration in eight weeks. Doulio AI shipped three role-based dashboards plus a full certification LMS on the same timeline.
Care-delivery FemTech (doula networks, coaching platforms, midwifery groups, lactation support) needs certification tracking, role-based access, compliance workflow automation, and session scheduling before it can sell to a single enterprise buyer. Founders scope the marketplace and forget the operational spine. The first enterprise contract stalls on a credentialing or audit question the product can't answer.
Doulio AI needed exactly this: multiple user roles, a certification LMS, scheduling, and enterprise-grade compliance, from idea to production in eight weeks, with no technical co-founder on the team. We delivered a working prototype in Week 1 covering all user roles, then role-based dashboards, an LMS with certification tracking, compliance workflow automation, and session scheduling. BAA-ready and production-grade by Week 8.
Every FemTech roadmap now has an AI layer: symptom forecasting, cycle prediction, personalised guidance. Most are built by piping PHI to a general model API with no boundary, no retention answer, and no hallucination mitigation. The first buyer who asks what leaves your environment ends the conversation. AI added without PHI boundaries is a compliance liability wearing a feature's clothes, and it is very hard to unwind once users depend on it.
PHI-safe model architecture, hallucination mitigation, and auditability are engineered as one system, not three patches. That is the 8-Week Clinical AI System Build. Khalisa™ users receive daily AI symptom forecasts drawn from cycle, wearable, and lab data, surfaced through clinician review.
Most women's health startups are pre-Series A. The product has to exist before the raise, and the raise depends on evidence. A firm optimised for an eighteen-month enterprise engagement spends the runway on discovery documents. The money runs out before the evidence exists.
A working HIPAA-compliant prototype lands in Week 1, before full commitment, so the vision is validated and the engagement de-risked early. Production-ready in eight weeks. Our P2P (Prototype-to-Production) Engine delivers 75% faster, and the model is built for early teams operating efficiently on limited runway.
The MVP ships, the agency rolls off, and the product context leaves with them. Six months later the roadmap is stalled and the next engagement starts by re-explaining the architecture. Women's health products live or die on sustained engagement, and sustained engagement needs continuous shipping.
Healthcare Product Acceleration gives you a dedicated Healthcare Product Pod: four HealthTech specialists shipping your roadmap continuously, month-to-month, backed by our AI Project Context Store so product knowledge compounds instead of resetting. The same model has run SkinSAFE by Mayo Clinic across 180+ production builds with zero disruption to live users over a two-year partnership.
FemTech Capability, Shipped
Computational modelling across the reproductive lifespan, fed by a unified data layer.
Care pathways, risk flags, and patient-facing guidance across life stages.
Tracking, coaching, and clinical handoff in one product.
Symptom intelligence and longitudinal tracking clinicians can review.
Client management, scheduling, messaging, and billing.
Role-based dashboards, certification LMS, and compliance workflow automation.
Multi-platform wearable data unified into a single clinical view.
Engagement and adherence built for sustained use.
Built for the Regulators FemTech Actually Answers To
HIPAA is the floor. It is also the bar your future clinical partners, payers, and enterprise buyers will hold you to, which is why we build to it whether or not you are a covered entity today. On top of it, women's health products need a privacy posture designed on purpose.
Download the free PHI-Safe AI Data Layer checklistReal Products. Real Outcomes.
Three women's health platforms, built by the same team you'd work with.
Trusted by Women's Health Founders
Bitsol helped us launch the beta. Our users started receiving daily AI symptom forecasts from cycle, wearable, and lab data right away, replacing guesswork with guided care.
Bitsol Technologies delivered three interconnected platforms, achieving 100% of the required core features. They helped us improve UX stability by 80% to 90%, increase website traffic and conversions, and onboard over ten testers. Many teams start strong and lose momentum, but Bitsol stayed the course.
Bitsol delivered the prototype in two weeks, enabling us to sign our first B2B customer before the platform was fully built. We launched a production ready platform within eight weeks. The team was responsive, quick, and organized, and their knowledge of startup culture stood out.
Eight Weeks, Four Stages
Core flows built and validated across 1–2 requirement clarification calls, with HIPAA compliance mapped from day one. Goal: validate the vision and de-risk the engagement before full commitment. Deliverables: a working HIPAA-compliant prototype with core features. Outcome: product-market fit and aligned expectations.
Requirements sharpened against real screens, compliance mapped to the architecture, and the practitioner or provider side scoped alongside the consumer product.
Production engineering, wearable and EHR integrations, and the practitioner side built in parallel with the consumer experience.
Production-ready and BAA-ready, with automated audit documentation shipped alongside the release.
How We Help Women's Health Startups
Questions founders ask first
Often not directly. HIPAA covers covered entities and their business associates, so a consumer cycle tracker with no provider relationship may sit outside it while still being regulated by the FTC and state health-data law. We build to HIPAA standards regardless, because it is the bar your clinical partners, payers, and enterprise buyers will apply.
Eight weeks to a production-ready build, with a working prototype in Week 1 before full commitment. Khalisa™, AuraFem, and Doulio AI each shipped on that timeline.
Yes. AuraFem came to us as a crashing FlutterFlow app with HIPAA exposure. We migrated it to a custom compliant build with zero downtime and added a practitioner portal in the same eight weeks.
Yes, with PHI boundaries drawn at architecture. Khalisa™ runs computational modelling across four unified data streams with clinician review and override at every step.
Retention, deletion, and access are designed deliberately for each product rather than inherited from a framework default, and consent is enforced at the data layer so a revocation actually takes effect downstream.
You own the code, infrastructure, and documentation. Yes to the BAA, with coverage confirmed across the subprocessors that touch PHI.
Building in Women's Health? Let's Scope It.
Bring the product idea, the compliance question, or the build that is already stuck. We will walk through scope, timeline, and where the regulatory lines fall for your roadmap.